Elicio Therapeutics, Inc.ELTXNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
20.28%
↑ 197% above average
Average (23q)
-20.94%
Historical baseline
Range
High:192.87%
Low:-473.67%
Volatility
-3183.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 20.28% |
| Q2 2025 | 6.01% |
| Q1 2025 | 20.33% |
| Q4 2024 | -30.28% |
| Q3 2024 | 5.31% |
| Q2 2024 | -6.67% |
| Q1 2024 | -9.04% |
| Q4 2023 | 12.80% |
| Q3 2023 | -38.50% |
| Q2 2023 | 0.36% |
| Q1 2023 | -30.93% |
| Q4 2022 | -3.31% |
| Q3 2022 | 7.41% |
| Q2 2022 | 56.98% |
| Q1 2022 | -198.98% |
| Q4 2021 | 192.87% |
| Q3 2021 | 13.63% |
| Q2 2021 | -194.60% |
| Q1 2021 | 55.29% |
| Q4 2020 | -19.55% |
| Q3 2020 | 32.91% |
| Q2 2020 | -473.67% |
| Q1 2020 | 78.79% |
| Q4 2019 | 0.00% |